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Cytotoxic T lymphocytes (CTL) are widely regarded as the develop AIDS, indicating that antiviral CTL responses do not provide absolute protection. In addition, it has been suggested most efficient component of the immune system in controlling viral infections [1] . In human immunodeficiency virus type 1 that HIV-1 -specific CTL might even be the major cause of (HIV-1) infection, the temporal relationship between the early progressive immunodeficiency, since CTL eliminate HIV-1 -recruitment of virus-specific CTL and the reduction of initial infected immunocompetent CD4 T cells and macrophages [9, viremia has been interpreted as active control of HIV-1 replica-10] and mediate inflammatory reactions in some AIDS-related tion by the immune response [2 -5] . In addition, vigorous and disorders [11, 12] . broadly directed HIV-1 -specific CTL responses coinciding Detailed longitudinal evaluations of the relationship between with low numbers of circulating HIV-1 -infected CD4 T cells dominant HIV-1 -specific CTL responses and markers of disare detected in most asymptomatic persons [6 -8] , suggesting ease progression are still lacking. The current knowledge was that HIV-1 -specific CTL may help to prevent viral replication. mainly derived from cross-sectional studies [13, 14] and by In contrast to the beneficial role of HIV-1 -specific CTL, it is longitudinal analysis of CTL specific for selected viral antigens well established that most HIV-1 -infected persons eventually [8, 15] . Therefore, we quantified the circulating precursors of CTL (CTLp) directed against 4 major gene products of HIV-1 (gag, reverse transcriptase [RT] , env, and nef) over time in cal examination. Blood samples were obtained for standard immu-HIV-1 seroconversion or seroprevalent entry into the cohort study was 10.7 years (range, 9.2-10.9). nologic and virologic tests, and both sera and viable cells were cryopreserved.
Clinical data and HLA class I type of study patients are summarized in table 1. CD4 T cell counts of all study subjects are shown By June 1995, 46 patients of 120 cohort participants with known in figures 1 and 2. date of HIV-1 seroconversion (calculated as midpoint between the last negative and the first positive HIV-1 antibody test) had We previously studied patients H90, H709, and H450 [8] . Analysis of their gag-specific CTL responses was repeated in parallel progressed to AIDS according to the 1987 CDC classification [17, 18] (median time to AIDS, 4.2 years; range, 0.5-9.5). For this to env-, RT-, and nef-specific responses in this setting. study, 6 progressors were selected (H39, H424, H450, H493, Recombinant (r) vaccinia viruses (VV). rVV were constructed H1211, and H1215) because they were nearest to the group's from the Copenhagen isolate of VV. The following rVV-expressmedian time to AIDS and had samples available for the entire ing single genes of HIV-1 LAI [23] were used for this study: follow-up period. The selected subjects developed AIDS within TG.1144 (gag) [24] , TG.4163 (RT) [7] , TG.3183 (env) [25], 3.1 and 6.0 years from seroconversion (median, 4.3) and did not TG.1147 (nef) [26] , and control-rVV 186poly, containing no spereceive antiretroviral therapy before AIDS diagnosis, with the excific insert. All constructs were provided by M. P. Kieny ception of patient H1215 who was treated with zidovudine and (Transgène, Strasbourg, France) and by Y. Rivière (Institut zalcitabine beginning 20 and 4 months before AIDS diagnosis, Pasteur, Paris). respectively.
In vitro restimulation and expansion of HIV-1-specific CTL. Long-term survivors were participants who met the following HIV-1-specific CTL were expanded in vitro by antigen-specific criteria: documented HIV-1 seropositivity for §9 years, absence stimulation as previously described [8, 27] . In brief, peripheral of AIDS-defining conditions (by the 1993 CDC case definition blood mononuclear cells (PBMC) isolated and cryopreserved at [19] ), mean CD4 T cells ú400/mL during both years 8 and 9 of different times during the study were thawed and resuspended in follow-up, and no use of antiretroviral drugs. By January 1996, complete medium (RPMI 1640; Life Technologies, Breda, Nether-21 cohort participants fit the above criteria for long-term survivors.
lands) containing antibiotics and heat-inactivated pooled human Six long-term survivors (H16, H90, H337, H448, H658, and H709) serum (10%) from 8-10 healthy HIV-1-seronegative blood dowere randomly selected from this group. Chemokine receptor nors. Eight serial dilutions of PBMC ranging from 26,000 to 246 (CCR)-5 genotyping was later done, and uneven distribution in cells/well were seeded in 12 replicate wells in 96-well roundthe selected group compared with that of the whole group of longbottom microtiter plates. Preliminary experiments with mixed populations of stimulator cells separately infected with 2 rVV or stimuterm survivors was ruled out (table 1) [20] . Median follow-up after lator cells infected with rVV expressing 2 HIV-1 gene products of CD3 monoclonal antibodies (MAbs) or phytohemagglutinin (PHA). The proliferative response was measured after 4 days by resulted in underestimation of CTL specificity at lower frequency (data not shown). Therefore, we preferred separate PBMC stimula-[ 3 H]thymidine incorporation. T cell reactivity was expressed as counts per minute. Samples from 5 healthy HIV-1-negative blood tion. The number (n j ) of replicates in each culture group was reduced from 24, as described [8] , to 12 to allow the simultaneous donors were included in each assay as controls. Results were expressed as percentage of the mean T cell reactivity of controls. analysis of up to 6 PBMC samples from each patient, using 4 separate stimulator cell populations (1 for each HIV-1 gene prodVirologic markers. Serum HIV-1 RNA levels were determined as previously described [31] using a single-tube quantitative uct). Coefficient of variation increases from 15% to 22% when n j is reduced from 24 to 12. In this way, considering a 95% confidence HIV-1 RNA nucleic acid sequence-based amplification assay with electrochemiluminescent-labeled probes (NASBA HIV-1 RNA interval (CI) equal to {2 SD, 2 frequencies (f 1 ú f 2 ) will be significantly different when f 1 00.44f 1 ú f 2 /0.44f 2 . This is solved QT; Organon Teknika, Boxtel, Netherlands). The virologic set point was calculated as the average of §3 HIV-1 RNA determinaas f 1 ú 2.57f 2 .
In a series of 217 CTLp frequency determinations in 22 PBMC tions within 0.5 log difference from the lowest determination after the initial decline but before the late rise (if applicable). samples from 4 patients, the average ({SD) 95% CI (one-sided) was 43.2% { 5.9%.
The frequency of circulating CD4 T cells productively infected with HIV-1 was determined using clonal virus isolation procedures To each well, 10 4 fixed stimulator cells and an equal number of feeder cells were added. Stimulator cells were autologous as described [32] . In brief, 12,500-25,000 PBMC from HIV-1-infected persons were cocultivated in 48 replicate wells with 10 5
Epstein-Barr virus-transformed B lymphoblastoid cell lines (B-LCL) infected with 5 MOI of rVV expressing single genes of 2-day PHA-stimulated PBMC from HIV-1-seronegative blood donors. HIV-1 replication was monitored by screening culture super-HIV-1 LAI and fixed with 1% (weight/vol) paraformaldehyde for 15 min at room temperature followed by incubation with 0.2 M glynatants for p24 production using a p24 capture ELISA. Statistical analysis of positive wells was done as described by Strijbosch et cine in PBS for 15 min. Feeder cells were generated prior to initiation of the experiments by polyclonal activation and expanal. [29] . Virus load was expressed as TCID/10 6 CD4 T cells. Biologic phenotype of HIV-1 viruses was determined as desion of PBMC obtained during each subject's early asymptomatic period as previously described [28] . Autologous feeder cells from scribed [22] . In brief, 10 6 PBMC from HIV-1-infected patients were cocultivated with MT-2 cells to determine the viral phenoa single PBMC sample were irradiated (30 Gy) and used for all samples from the same patient.
type. Cultures were monitored microscopically to check for syncytium formation. Microcultures were maintained for 15 days at 37ЊC with 5% CO 2 . At days 2 and 9, cultures were fed with complete medium
Statistics. Correlations between pairs of variable parameters were analyzed by Spearman's rank correlation test. For comparison containing recombinant interleukin-2 (rIL-2; 360 IU/mL final concentration; provided by R. Rombouts, Chiron Benelux, Amsterof parameters at cross-sections, the Mann-Whitney U test was used. dam). At day 7 they were restimulated with 10 4 fixed stimulator cells and rIL-2. On day 15, wells were split and effector cells were tested for cytotoxicity.
Cytotoxicity assays. Standard 51 chromium-release assays were Results done as previously described [8, 27] . In brief, autologous B-LCL were infected with 5 MOI rVV expressing single HIV-1 gene ; figure 1 ). Primary viruses isolated from the 6 sponse to each HIV-1 protein was quantified as the percentage of the total CTLp frequency at each time point and related to long-term survivors were always of the non-SI (syncytiuminducing) phenotype.
HIV-1 -specific CTL responses and virus load in long-term
virus load at that time. Correlations were made for 68 pairs of CTL and RNA load measures and for 56 pairs of CTL and HIV-1 -specific CTL responses and virus load during progression to AIDS. CTL activity against the 4 HIV-1 gene numbers of circulating infected CD4 T cells. For the latter, 36 paired determinations were done on the same sample; the other products tested was also observed in the progressors studied, except for nef-and env-specific CTL, which were undetectable 20 were obtained from the nearest samples obtained within a 6-month interval. When all determination pairs were considin subjects H1211 and H39, respectively.
Two apparently distinct patterns of HIV-1 -specific CTL ered, total CTLp were not significantly correlated with virus load. However, when individual specificities were considered, responses in relation to virus load were observed. In the 2 progressors (H39 and H493) with the shortest interval from both the frequency and the percentage of gag-specific CTL negatively correlated with HIV-1 RNA load (r s Å 0.303, P Å HIV-1 seroconversion to AIDS (3.2 and 3.3 years, respectively), vigorous HIV-1 -specific CTL responses were observed .012; r s Å 0.342, P Å .005, respectively). When we limited the analysis to the 21 determination pairs obtained within 24 (peak values, 5188 and 2413 total HIV-1 -specific CTLp/10 6 PBMC). These were maintained to AIDS diagnosis. Shortly months after seroconversion (or seroprevalent entry in 2 cases), a more significant negative correlation was seen between the thereafter, HIV-1 -specific CTL responses significantly deteriorated. Increasing numbers of HIV-1 -infected CD4 T cells percentage of gag-specific CTL and both HIV-1 RNA and circulating infected CD4 T cells (r s Å 0.55, P Å .01; r s Å occurred early in both patients in the face of already established and vigorous HIV-1 -specific CTL responses (figure 2). In pa-0.639, P Å .006, respectively). The negative association between gag-specific CTL responses and virus load was reflected tient H39, this was associated with emergence of SI variants as early as 18 months after seroconversion. Serum RNA levels in persistently predominant gag-specific responses in 4 of the 6 long-term survivors. In progressors, even when an initially were always high in these 2 patients (ú10 4.46 copies/mL). Thus, lack of virus control was observed in progressors H39 and predominant gag-specific response was found, it was not maintained over time ( figure 3 ). The differences in the composition H493 despite HIV-1 -specific CTL responses that were comparable in magnitude and breadth to those in persons with more of the HIV-1 -specific CTL responses could not be related to patient HLA type. When the 2 patient groups were compared protracted asymptomatic infection.
In the other patients, HIV-1-specific CTL activity increased at the time of each subject's highest HIV-1 -specific CTLp frequency, the percentage of gag-specific CTLp was the only after seroconversion, peaking at 17-48 months. Peak values were 964-2392 total HIV-1-specific CTLp/10 6 PBMC (median, immune parameter significantly higher in long-term survivors. The 2 groups differed also for the set point of HIV-1 RNA 1307). In 3 of these patients, initial reduction (0.6-2.0 log) of viral RNA levels was seen in association with peak CTL activity.
and to a lesser extent for numbers of CD4 T cells (table 2) . Deterioration of immune functions and disease progression. The fourth patient in this group (H450) had virtually undetectable viral RNA for the first 6 months after HIV-1 seroconversion.
Declining CD4 T cells and deterioration of polyclonal T cell reactivity are hallmarks of progression to AIDS [34] . Kinetics Four of 5 monthly samples produced negative results, and serum obtained at month 5 contained 10 3.28 copies/mL. The initially low of in vitro T cell reactivity to polyclonal stimuli and total HIV-1 -specific CTLp in the patients progressing to AIDS are shown virus load may explain this patient's relatively slow expansion of HIV-1-specific CTL. HIV-1 RNA levels stabilized in each patient in figure 4 . Sequential decline of CD3-and PHA-induced T cell reactivity, respectively, was observed during progression at relatively high virologic set points (range, 10 4.08 -10 5.72 copies/ mL). In these 4 patients, HIV-1-specific CTLp frequencies deto AIDS, confirming previous observations [35] . Maintenance of steady HIV-1 -specific CTLp frequency appeared to be reclined before AIDS diagnosis to values 12-to 23-fold lower than peak values. Decline of HIV-1-specific CTL responses was lated to preserved reactivity to PHA. In all 6 progressors, no substantial loss of CTL activity was seen as long as PHAinvariably associated with loss of CD4 T cells and steep increases in the frequency of productively infected CD4 T cells (figure 2).
induced T cell response was 30% above that of controls, a threshold level previously established as predictive for rapid SI viruses were detected in association with increasing numbers of infected CD4 T cells in patients H450 and H1215 at 4 and disease progression [34] . Analysis of 26 paired determinations of total HIV-1 -specific CTLp and either CD3 MAb-or PHA-12 months before AIDS diagnosis, respectively. Thus, increasing numbers of circulating productively infected cells were observed induced T cell reactivity in the period after maximal CTL / 9d52$$oc12 08-24-98 13:02:26 jinfas UC: J Infect responses in progressors revealed a highly significant positive subjects mounted specific CTL responses against all major viral correlation between HIV-1 -specific CTLp frequency and T proteins. The persistence and in some cases the continuous cell reactivity to PHA in vitro (r s Å .752; P õ .001) and, to expansion for 6 or 7 years of the circulating pool of HIV-1 -a lesser extent, between HIV-1 -specific CTLp frequency and specific CTLp distinguished the long-term survivors from the CD3 MAb-induced T cell proliferation (r s Å .569; P õ .005).
progressors studied. This suggests that even in the presence of low virus load, continuous antigenic stimulation maintains a large pool of specific T lymphocytes and, in agreement with Discussion other observations [8, 13, 37 -40] , that immune control may contribute to maintenance of the asymptomatic phase of The relevance of CTL responses in limiting HIV-1 replica-HIV-1 infection. tion is unclear, even though the accumulation of mutations HIV-1 -specific CTL response has been assigned a crucial within putative viral epitopes of CTL recognition suggests efrole in reducing the initial viremia on the basis of temporal ficient pressure exerted by the immune system on the virus relationships in kinetics [2] and a weak inverse correlation [36] . We attempted to define characteristics of the HIV-1 -between env-specific CTLp and HIV-1 RNA load [5] . Howspecific CTL response that could be responsible for the limitaever, the significant difference in virologic set point between tion of viral replication by comparing balanced groups of longthe 2 groups analyzed in the present study can hardly be exterm survivors and persons with relatively rapid progression to plained by the vigor of the CTL responses. Although the prog-AIDS chosen within a homogeneous population of HIV-1 -infected subjects. We found that virtually all HIV-1 -infected ressors in our study had a relatively short AIDS-free interval, / 9d52$$oc12 08-24-98 13:02:26 jinfas UC: J Infect the magnitude of HIV-1 -specific CTL responses, as shown by subjects who exhibited a CTL response to a single epitope in gag and only after the late emergence of an escape mutant the frequency of cells reacting with conserved epitopes in the HIV-1 LAI sequence, was strikingly similar to that observed in experienced uncontrolled viral replication, decline of circulating CTLp, and disease progression [42] . The continuing followlong-term survivors and reached its maximum significantly earlier than in long-term survivors. Differences in specificity may up of our subjects who had highly diversified CTL responses will clarify whether changes in the specificity of the CTL reaccount for the heterogeneous outcome. The long-term survivors had a persistently predominant gag-specific response that sponse are accompanied by clinical deterioration. gag-specific T cell responses have often been related to a more favorable was not seen in the progressors. This predominance may be interpreted either as reflecting the recognition of conserved course of infection, when CTL [43, 44] and lymphoproliferative responses [45] are analyzed. A recent report of strong p24-epitopes that the virus cannot mutate without disadvantage or as the simultaneous recognition of several epitopes in the same stimulated in vitro lymphoproliferative responses in peripheral blood of 2 long-term HIV-infected survivors and in 3 subjects protein. The detection of CTL responses to rev and tat exclusively in long-term survivors, although quantitatively small, treated with highly active antiretroviral therapy early after infection has revived interest in this issue and suggests a possible could be interpreted in the same fashion [41] . Epitope variation related to higher virus replication rate, however, must be conprotective role [46] . Differences in specificity of the CTL response could be exsidered as a possible cause of rapid changes in the predominant CTL specificity and, given the readout system, which is based plained by genetic background, but no such association was found in our study subjects. Even though progressor H424 on a single antigen sequence, may account for discrepancies in the response patterns seen with individual HIV-1 proteins.
and long-term survivor H658 were fully matched for CCR5 genotype, HLA type (table 1) , and TAP alleles (not shown) Although the gag-specific CTL response is common in most HIV-1 -infected subjects [7, 8, 13] , the simultaneous response [47] , the duration of their HIV-1 -specific CTL responses was strikingly different, indicating that viral properties or other host to the major viral proteins shown in this study demonstrates that its relative predominance might be a key aspect of a protective cofactors are likely involved. The deterioration of HIV-1 -specific CTL responses obimmune response. It is of interest that in 4 long-term survivors the predominant gag-specific CTL response persisted for sevserved during progression to advanced HIV-1 infection was not clearly related to patient clinical status. In 2 progressors, eral years and in 3 it was later replaced by a different response without clear changes in patient status ( figure 3 ). These obserwe observed high serum HIV-1 RNA levels and increasing numbers of infected cells in the face of strong and ongoing vations are somewhat similar to those of a group of HLA-B27 HIV-1 -specific CTL responses. In the remaining progressors, This study adds to the growing body of evidence that HIV-1 -specific CTL may help limit HIV-1 replication, thereby a steep rise in HIV-1 -infected CD4 T cells and progression to AIDS occurred only after HIV-1 -specific CTL activity diallowing maintenance of the asymptomatic phase of infection. The association of a dominant gag-specific CTL response with minished. Loss of HIV-1 -specific CTL was observed in close association with deterioration of general T cell function and long-term survival should be taken into account in the design of preventive and, given the possibilities opened by current numbers of CD4 T cells. In our study, the in vitro detection of HIV-1 -specific CTL activity appeared to be strictly associhighly active therapies [48] , of therapeutic vaccines. ated with the maintenance of T cell reactivity to PHA. In agreement with previous studies [34, 35] , the deterioration of
